Abstract
Summary: Apolipoprotein AI Milano (ApoAIMilano) was expressed as a fusion protein in transgenic safflower seeds. High levels of expression corresponding to 7 g of ApoAIMilano per kilogram of seed have been identified in a line selected for commercialization. The ApoAIMilano fusion protein was extracted from seed using an oilbody-based process and matured in vitro prior to final purification. This yielded a Des-1,2-ApoAIMilano product which was confirmed by biochemical characterization including immunoreactivity against ApoAI antibodies, isoelectric point, N-terminal sequencing and electrospray mass spectrometry. Purified Des-1,2-ApoAIMilano readily associated with dimyristoylphosphatidylcholine in clearance assays comparable to Human ApoAI. Its biological activity was assessed by cholesterol efflux assays using Des-1,2-ApoAIMilano:1-palmitoyl-2-oleoyl phosphatidylcholine complexes in vitro and in vivo. This study has established that high levels of biologically functional ApoAIMilano can be produced using a plant-based expression system. © 2010 SemBioSys Genetics Inc. Plant Biotechnology Journal © 2010 Society for Experimental Biology, Association of Applied Biologists and Blackwell Publishing Ltd.
Author supplied keywords
Cite
CITATION STYLE
Nykiforuk, C. L., Shen, Y., Murray, E. W., Boothe, J. G., Busseuil, D., Rhéaume, E., … Moloney, M. M. (2011). Expression and recovery of biologically active recombinant Apolipoprotein AIMilano from transgenic safflower (Carthamus tinctorius) seeds. Plant Biotechnology Journal, 9(2), 250–263. https://doi.org/10.1111/j.1467-7652.2010.00546.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.